The critical contribution of Myc to maintaining rapid tumor cell growth and/or viability both in vitro and in vivo has also been demonstrated in many transformed cell types and a variety of neoplasms, including those arising in bone, the lymphatic system and the liver (Shachaf et al., 2004; Wu et al., 2007; Wang et al., 2008; Gabay et al., 2014; Dolezal et al., 2017). Here, MYC is linked to neoplasm.